Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present ProQR Therapeutics N.V. (NASDAQ: PRQR).

Full DD Report for PRQR

You must become a subscriber to view this report.


Recent News from (NASDAQ: PRQR)

ProQR prices $90.6M public offering of ordinary shares
ProQR Therapeutics N.V. (NASDAQ: PRQR ) prices its previously announced public offering of 5.75M ordinary shares at a price of $15.75 per share for gross proceeds of ~$90.6M. More news on: ProQR Therapeutics, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: September, 07 2018 05:57
ProQR Prices $90.6 Million Underwritten Public Offering of Ordinary Shares
LEIDEN, Netherlands and CAMBRIDGE, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a biopharmaceutical company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today announce...
Source: GlobeNewswire
Date: September, 07 2018 04:21
Premarket Losers as of 9:05 am (9/6/2018)
LE   -15%  on Q2 earnings . More news on: Lands' End, Inc., Iovance Biotherapeutics, Inc., Barnes & Noble Inc, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 06 2018 09:12
Today's Research Reports on Stocks to Watch: ProQR Therapeutics and Sangamo Therapeutics
NEW YORK, NY / ACCESSWIRE / September 6, 2018 / Shares of one stock soared over 120% on positive results from a trial while the other collapsed on its trial results. ProQR was the winner with a gain of over 120% while Sangamo Therapeutics sank nearly 24%. RDI Initiates Coverage on: ProQ...
Source: ACCESSWIRE IA
Date: September, 06 2018 08:00
After Hours Gainers / Losers (09/05/2018)
Top Gainers: CLDR +12.1% . VRNT +10.7% . EYPT +8.5% . AVAV +6.3% . MXWL +2.9% . More news on: Cloudera, Inc., Verint Systems Inc., EyePoint Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 05 2018 17:38
ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares
LEIDEN, Netherlands and CAMBRIDGE, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a biopharmaceutical company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today anno...
Source: GlobeNewswire
Date: September, 05 2018 16:01
Midday Gainers / Losers (09/05/2018)
Gainers: PRQR +62% . MNKD +33% . SBOT +19% . VCEL +18% . NSU +17% . SYBX +15% . CORV +15% . VRA +15% . MVIS +14% . IGC +13% . More news on: ProQR Therapeutics, MannKind Corporation, Stellar Biotechnologies Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 05 2018 12:47
Biotech Stocks & Marijuana Stocks Moving Higher on Wednesday
CORAL GABLES, FL / ACCESSWIRE / September 5, 2018 / This month marks the beginning of "back to school season" and more importantly the start of the big push for reform as well as new policies in healthcare. In addition to this, there are a number of industry conferences that will be sure to ...
Source: ACCESSWIRE IA
Date: September, 05 2018 11:20
Premarket Gainers as of 9:05 am (09/05/2018)
PRQR +66%  on positive interim results from Phase 1/2 clinical trial of QR-110 in LCA10 patients. More news on: ProQR Therapeutics, Cronos Group, Inc., Nevsun Resources Ltd., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 05 2018 09:21
ProQR announces positive interim results from Phase 1/2 clinical trial of QR-110 in LCA10 patients
ProQR Therapeutics N.V. (NASDAQ: PRQR ) announces results from a planned interim analysis of its Phase 1/2 trial of QR-110 in patients with Leber’s congenital amaurosis 10 (LCA10) due to the p.Cys998X mutation in the CEP290 gene. LCA10 typically leads to childhood blindness and ha...
Source: SeekingAlpha
Date: September, 05 2018 05:56

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0816.4015.8016.9015.752,379,030
2018-05-175.005.055.254.90207,294
2017-10-104.554.554.64994.5549,557
2017-10-094.604.554.654.5536,367
2017-10-064.654.654.704.6059,347

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1011,643185,6366.2720Cover
2018-12-0722,15936,25261.1249Short
2018-12-0644,79073,91260.5991Short
2018-12-04206,849260,69779.3446Short
2018-12-0315,982108,50414.7294Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PRQR.


About ProQR Therapeutics N.V. (NASDAQ: PRQR)

Logo for ProQR Therapeutics N.V. (NASDAQ: PRQR)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: PRQR)

      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: May, 16 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: May, 10 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: April, 23 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: April, 12 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: April, 11 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: April, 09 2018
      Annual and transition report of foreign private issuers under sections 13 or 15(d)
      Filing Type: 20-FFiling Source: edgar
      Filing Date: March, 30 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: February, 28 2018
      Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
      Filing Type: 6-KFiling Source: edgar
      Filing Date: February, 20 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: February, 14 2018

       

       


      Daily Technical Chart for (NASDAQ: PRQR)

      Daily Technical Chart for (NASDAQ: PRQR)


      Stay tuned for daily updates and more on (NASDAQ: PRQR)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: PRQR)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PRQR is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of PRQR and does not buy, sell, or trade any shares of PRQR. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/